San Diego has developed into one of the most important biotechnology and life sciences centres in the United States. The region brings together biotechnology companies, pharmaceutical businesses, research organisations, universities, medical technology firms and specialised scientific talent. Its strongest clusters can be found around areas such as Torrey Pines, La Jolla, Sorrento Valley and University City.
The scale of the local industry is significant. San Diego County recorded more than 34,000 biotechnology jobs in 2022, alongside thousands of additional positions across biopharmaceuticals, medical devices, research and scientific tools. Major organisations in the region include Illumina, Dexcom, Neurocrine Biosciences, Halozyme Therapeutics and many others.
The following companies represent different areas of San Diego’s biotechnology ecosystem, from genomic sequencing and drug development to gene therapy and advanced drug-delivery technologies.
Illumina
Illumina is one of the most recognisable biotechnology companies associated with San Diego. Headquartered in the city, the company develops genomic sequencing and array technologies used by researchers, healthcare organisations and other life sciences businesses.
Genomic sequencing allows scientists to examine DNA and identify genetic information that can support research into diseases, inherited conditions and other biological questions.
Illumina’s technology has helped make large-scale genomic analysis increasingly accessible to laboratories around the world. The company remains an important part of San Diego’s biotechnology identity and has helped attract additional genomics businesses and scientific talent to the region.
Dexcom
Dexcom is a San Diego-based healthcare technology company known for continuous glucose monitoring systems. Its wearable devices allow people with diabetes to monitor glucose levels using sensors rather than relying exclusively on conventional testing methods.
The company combines biotechnology, sensor technology, software and data analysis to create connected diabetes-management products.
Dexcom has become one of San Diego’s largest life sciences businesses. The San Diego Regional EDC lists the company among the area’s key life sciences organisations, while recent industry data identifies Dexcom as one of the region’s largest life sciences employers.
Neurocrine Biosciences
Neurocrine Biosciences is a biopharmaceutical company headquartered in San Diego. Its research and development activities focus on neurological, endocrine and other specialised medical conditions.
The company develops medicines through research, clinical development and commercialisation. Its presence illustrates the strength of San Diego’s pharmaceutical and drug-development ecosystem.
Neurocrine is also one of the established biotechnology businesses that has helped make the region an important location for pharmaceutical research and specialised scientific careers.
Halozyme Therapeutics
Halozyme Therapeutics is a San Diego biotechnology company focused on drug-delivery technology. Its work includes technologies designed to change how certain medicines are administered.
One of the company’s best-known technologies is ENHANZE, which uses recombinant human hyaluronidase to facilitate subcutaneous delivery of certain biologic medicines.
Drug delivery is an important part of biotechnology because developing an effective medicine is only one part of bringing a treatment to patients. The method used to deliver a therapy can also influence convenience and treatment experience.
Halozyme’s focus on drug-delivery technology gives it a distinctive position within San Diego’s biotechnology ecosystem.
Avidity Biosciences
Avidity Biosciences is a San Diego biotechnology company working in RNA therapeutics. Its research focuses on developing medicines designed to address diseases that can be difficult to treat using conventional approaches.
The company’s technology platform combines antibodies with oligonucleotide-based medicines, with the aim of delivering therapeutic molecules to specific cells.
RNA-based treatments have become an important area of biotechnology research, particularly for genetic and rare diseases. Avidity is one of the San Diego companies contributing to this expanding field.
Element Biosciences
Element Biosciences is a San Diego genomics company developing DNA sequencing technology. The company is part of a newer generation of businesses seeking to improve sequencing platforms and expand the capabilities available to researchers.
Sequencing technology has applications across medical research, genomics, drug discovery and other scientific fields. Competition among sequencing companies can also encourage the development of faster, more flexible and potentially more accessible technologies.
Element’s presence reinforces San Diego’s position as a major centre for genomics and scientific tools. The company is listed among the region’s notable life sciences organisations and has attracted significant investment.
Maravai LifeSciences
Maravai LifeSciences provides technologies and products used in the development and production of biological medicines and other life sciences applications.
The company operates through specialised businesses serving areas such as nucleic acid production, biological research and biopharmaceutical development.
Companies like Maravai are important because biotechnology depends on a large ecosystem of suppliers and technology providers. Not every life sciences company develops a finished medicine; many provide the tools, materials and manufacturing capabilities needed by researchers and drug developers.
Maravai is listed among San Diego’s key life sciences companies by regional economic-development organisations.
Poseida Therapeutics
Poseida Therapeutics is a biotechnology company focused on cell and gene therapies. Its research has included CAR-T approaches designed to target cancer and other serious diseases.
Cell and gene therapy is one of the more advanced areas of modern biotechnology. Instead of relying only on conventional small-molecule medicines, these approaches can involve modifying cells or using genetic material to influence disease processes.
Poseida’s work contributes to San Diego’s growing presence in advanced therapeutic research and is part of the region’s broader cell and gene therapy ecosystem.
Gossamer Bio
Gossamer Bio is a biopharmaceutical company based in San Diego that focuses on developing medicines for serious diseases.
The company has worked across areas including immunology, inflammation and pulmonary diseases. Its research programmes demonstrate how San Diego’s biotechnology sector includes companies focused on specialised therapeutic areas rather than a single broad category of medicine.
Gossamer Bio is also among the companies highlighted in recent San Diego life sciences industry data.
Biosplice Therapeutics
Biosplice Therapeutics is a San Diego biotechnology company focused on developing medicines based on discoveries in regenerative medicine and biology.
The company’s research has explored biological pathways involved in tissue regeneration and disease. Its approach illustrates the variety of scientific concepts being investigated by San Diego biotechnology companies.
Biosplice appears among the larger funded life sciences businesses in recent San Diego industry data, demonstrating the continued investment available to companies pursuing advanced therapeutic research.
Why San Diego Is a Major Biotechnology Hub
San Diego’s biotechnology industry has developed through the interaction of research institutions, universities, investors, entrepreneurs and established companies.
Institutions including UC San Diego, Scripps Research, Salk Institute and Sanford Burnham Prebys contribute scientific research and help develop the talent required by biotechnology businesses. The concentration of these organisations around the Torrey Pines area has also encouraged collaboration and the creation of new companies.
The region has a broad life sciences base rather than relying on one type of business. Biotechnology, biopharmaceuticals, medical devices, research services and scientific tools all contribute to the local ecosystem.
This diversity gives startups and established companies opportunities to collaborate with research organisations, clinical experts and specialised suppliers.
The Future of San Diego Biotechnology
San Diego’s biotechnology sector is moving into several important areas, including genomic medicine, RNA therapeutics, cell and gene therapy, precision medicine, drug delivery and advanced scientific tools.
Artificial intelligence is also becoming increasingly relevant to drug discovery and biological research. Computational approaches can help researchers analyse complex datasets, identify potential targets and improve parts of the discovery process.
At the same time, biotechnology companies face challenges such as research costs, clinical-development timelines, regulatory requirements and access to capital. Recent industry data indicates that San Diego continues to have a large and diverse life sciences ecosystem, although funding conditions remain an important consideration for emerging businesses.
Final Thoughts
The leading biotechnology companies in San Diego represent a broad range of scientific and commercial activities. Illumina is strongly associated with genomic sequencing, Dexcom with continuous glucose monitoring, Halozyme with drug delivery, while companies such as Avidity Biosciences and Poseida Therapeutics are working in advanced therapeutic fields.
Alongside these established names, companies such as Element Biosciences, Maravai LifeSciences, Gossamer Bio and Biosplice Therapeutics contribute to the region’s expanding biotechnology ecosystem.
With major research institutions, specialised talent, established businesses and a growing collection of emerging companies, San Diego continues to be an important centre for biotechnology innovation in the United States.
